Ascenta Capital

About

Ascenta Capital describes itself as a venture firm that invests in biotechnology companies developing multiple therapeutic medicines from a common platform. The firm focuses on early-stage biotech companies — typically those advancing through Phase 1 and Phase 2 clinical trials — and works with them to support their clinical, regulatory, manufacturing, and capital strategy needs. Ascenta Capital provides concentrated investment and strategic guidance, partnering closely with management teams to help translate scientific research into therapies for patients. The firm pursues a portfolio-construction approach that balances risk by backing multi-asset biotech platforms rather than single-asset startups.

Investment Focus

Stages

series-a series-c

Sectors

fintech

Location

New York, US